EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients
NCT01942005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2014-12-04
Summary
Detection of mutation / specific polymorphism of the EVER/TMC6 and/or EVER/TMC8 gen.
Conditions
- Immunosuppression
- Neoplasm
Sponsors & Collaborators
-
Andreas Arnold
lead OTHER
Principal Investigators
-
Andreas Arnold, MD · University Hospital Basel, Dermatology, CH-4031 Basel
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 ·Status: COMPLETED
-
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma
NCT03692533 ·Status: UNKNOWN ·Phase: NA
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma
NCT05889481 ·Status: UNKNOWN
-
Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples
NCT02580799 ·Status: COMPLETED
-
Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
NCT01221766 ·Status: COMPLETED
-
Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells
NCT00020072 ·Status: COMPLETED ·Phase: NA
-
A Study of Patients With AIDS Syndrome
NCT00001120 ·Status: COMPLETED
-
Genetic Susceptibility to Oncogenic Viruses
NCT00341484 ·Status: COMPLETED
-
Genomic Investigation of Unusual Responders
NCT03740503 ·Status: RECRUITING
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Study on Infectious Mononucleosis in Munich
NCT06002802 ·Status: COMPLETED
-
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
NCT07327489 ·Status: RECRUITING
-
Comparison of Immune Response Following Surgical Management of Renal Tumors
NCT00289146 ·Status: TERMINATED
-
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
NCT02664389 ·Status: TERMINATED ·Phase: NA
-
Genomic Analysis of Families With a History of Discordant Cancers
NCT04860453 ·Status: RECRUITING
-
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
NCT06605417 ·Status: RECRUITING
-
Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804 ·Status: COMPLETED
-
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 ·Status: COMPLETED
-
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
NCT05119829 ·Status: UNKNOWN
-
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787 ·Status: TERMINATED
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Molecular Biology of Anal Cancer in HIV-Positive Patients
NCT00952874 ·Status: COMPLETED
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN